Jill Drachenberg

Jill Drachenberg

Reporter, Health Plan Weekly and Radar on Drug Benefits

Latest from Jill Drachenberg

PBMs Must Prepare For Revival Of Drug Price Transparency Requirements

Experts say PBMs should become familiar with transparency rules and prepare to release data, although more legal wrangling could occur.

Kennedy’s Pullback of Public Comment Policy Make May Rules Vulnerable to Lawsuits

The Health and Human Services Department's decision to eliminate the Richardson Waiver may be a blow for transparency, but will not completely eliminate scrutiny of regulations, experts said.

Kennedy’s Pullback of Public Comment Policy Make May Rules Vulnerable to Lawsuits

The Health and Human Services Department's decision to eliminate the Richardson Waiver may be a blow for transparency, but will not completely eliminate scrutiny of regulations, experts said.